Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint.
about
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cellsEvaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections.Daptomycin.Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections.Daptomycin - a novel antibiotic against Gram-positive pathogens.In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.Update on daptomycin: the first approved lipopeptide antibiotic.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infectionIntravitreal daptomycin: a safety and efficacy studyImpact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms.In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.Muscle pain associated with daptomycin.Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia.
P2860
Q24682375-BF41D64D-A472-495B-A60D-A040FAEE95C8Q33239640-8D211E2B-2FF2-47EB-909E-9534944FE805Q33883648-0BE8DBAE-9D8C-4263-B852-127BD23C4C60Q34330270-69483F83-71D4-4F10-97D6-5A453E9E1C84Q34510589-9265A481-6D44-4D7E-8D7B-98A296BB472FQ35166213-4B8FC65A-D352-41EC-ADD3-6FD0EE56ED01Q35166807-58B970D4-1724-4526-8447-9F7830FA5E05Q35637066-C46B29DF-3130-4A01-B36A-5F6840C2E647Q35701450-5A746C24-B984-4554-8D77-768B6E66567BQ35871928-1D45D4FF-53A8-45FF-B6A2-CCF487136871Q35925535-FC670F71-813A-453D-9BA9-ACF0EC127363Q36492244-8DD42093-A433-46E6-A418-DC5BF98B166AQ36521880-282353F8-A881-48F9-9571-24C41A9EF157Q36718474-7862A9AF-0F59-4D81-81ED-027C906E1422Q36879791-A8A3A4E2-3242-4BC0-9104-E9BA3E7320F9Q37183015-30B6324D-9D66-4C53-9B5D-1BDB8E17BCD9Q37625071-EA4042FD-C6B1-497B-B309-9B82D2DEC570Q38474869-3268AB13-F469-4BCC-A8C9-7E88F3C166F8Q39686976-12EBFC19-FF9A-4AE3-90B5-2AAF652AFB31Q39792691-D3B6F49C-3183-45FC-B01E-1046D29CFA33Q42549999-C48884A6-2224-4D22-9603-011D4D26950AQ43796988-56ED30D1-3C91-42FE-B43F-39126BA68232Q45059184-CE2DD645-B16D-4123-BCCC-2E89DF2FB347Q46832044-3300E97F-6139-4761-B163-A2BC15F0BE5BQ46987530-F065D96D-6B64-4D22-B39A-52136F54ED8D
P2860
Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Activity of daptomycin against ...... ion of a tentative breakpoint.
@en
Activity of daptomycin against ...... ion of a tentative breakpoint.
@nl
type
label
Activity of daptomycin against ...... ion of a tentative breakpoint.
@en
Activity of daptomycin against ...... ion of a tentative breakpoint.
@nl
prefLabel
Activity of daptomycin against ...... ion of a tentative breakpoint.
@en
Activity of daptomycin against ...... ion of a tentative breakpoint.
@nl
P2093
P356
P1476
Activity of daptomycin against ...... ion of a tentative breakpoint.
@en
P2093
P304
P356
10.1093/JAC/48.4.563
P407
P577
2001-10-01T00:00:00Z